Patents by Inventor Gyorgy Hasko

Gyorgy Hasko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating infection including sepsis via P2X receptor modulation
    Patent number: 10806747
    Abstract: Methods of treating infection including sepsis through modulation of a P2X receptor are provided.
    Type: Grant
    Filed: July 13, 2018
    Date of Patent: October 20, 2020
    Assignee: Rutgers, The State University of New Jersey
    Inventor: Gyorgy Hasko
  • METHODS FOR TREATING INFECTION INCLUDING SEPSIS VIA P2X RECEPTOR MODULATION
    Publication number: 20190015438
    Abstract: Methods of treating infection including sepsis through modulation of a P2X receptor are provided.
    Type: Application
    Filed: July 13, 2018
    Publication date: January 17, 2019
    Inventor: Gyorgy Hasko
  • Attenuating or treating sepsis or septic shock
    Patent number: 9987336
    Abstract: Methods for attenuating or treating, or reducing the mortality of sepsis or septic shock using an ectonucleotidase such as CD39 or CD73 are provided.
    Type: Grant
    Filed: August 9, 2013
    Date of Patent: June 5, 2018
    Assignee: Rutgers, The State University of New Jersey
    Inventors: Gyorgy Hasko, Zoltan Nemeth
  • ATTENUATING OR TREATING SEPSIS OR SEPTIC SHOCK
    Publication number: 20150209413
    Abstract: Methods for attenuating or treating, or reducing the mortality of sepsis or septic shock using an ectonucleotidase such as CD39 or CD73 are provided.
    Type: Application
    Filed: August 9, 2013
    Publication date: July 30, 2015
    Inventors: Gyorgy Hasko, Zoltan Nemeth
  • Sepsis Prevention Through Adenosine Receptor Modulation
    Publication number: 20090041751
    Abstract: Methods for treating sepsis or septic shock in a patient comprising administering to said patient a therapeutically effective amount of a composition containing an adenosine A2a receptor antagonist.
    Type: Application
    Filed: February 1, 2006
    Publication date: February 12, 2009
    Applicant: UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY
    Inventors: Gyorgy Hasko, Zoltan Nemeth, David Bleich, Edwin Deitch